本页面由Tiger Trade Technology Pte. Ltd.提供服务

Trevi Therapeutics Inc.

11.33
-0.4700-3.98%
盘后11.330.00000.00%16:58 EDT
成交量:142.95万
成交额:1,621.13万
市值:14.53亿
市盈率:-35.70
高:11.97
开:11.69
低:11.01
收:11.80
52周最高:14.39
52周最低:4.85
股本:1.28亿
流通股本:9,708.75万
量比:0.87
换手率:1.47%
股息:- -
股息率:- -
每股收益(TTM):-0.3173
每股收益(LYR):-0.3173
净资产收益率:-30.23%
总资产收益率:-20.26%
市净率:7.93
市盈率(LYR):-35.70

数据加载中...

2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

SEC问询函

Form CORRESP - Correspondence
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/29

重要事件披露

Form 8-K - Current report
2023/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/11

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/04/14

重要事件披露

8-K - Current report
2023/04/11

关联方拟减持公告

144 - Report of proposed sale of securities
2023/03/16

重要事件披露

8-K - Current report
2023/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals